Nucleic acid-loaded poly(beta-aminoester) nanoparticles for cancer nano-immuno therapeutics: the good, the bad, and the future
Open Access
- 3 May 2024
- journal article
- research article
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 14 (12) , 3477-3493
Abstract
Immunotherapy has emerged as a promising approach to cancer treatment, offering improved survival rates and enhanced patients’ quality of life. However, realizing the full potential of immunotherapy in clinical practice remains a challenge, as there is still plenty of room for modulating the complexity of the human immune system in favor of an antitumor immunogenicity. Nanotechnology, with its unique properties, holds promise in augmenting the efficacy of cancer immunotherapies in biotherapeutic protection and site- and time-controlled delivery of the immune modulator biologicals. Polymeric nanoparticles are promising biomaterials among different nanocarriers thanks to their robustness, versatility, and cost-efficient design and production. This perspective paper overviews critical concepts in nanometric advanced delivery systems applied to cancer immunotherapy. We focus on a detailed exploration of the current state of the art and trends in using poly(beta-aminoester) (pBAE) polymers for nucleic acid-based antitumor immunotherapies. Through different examples of the use of pBAE polymers reported in the literature, we revise the main advantages these polymers offer and some challenges to overcome. Finally, the paper provides insights and predictions on the path toward the clinical implementation of cancer nano-immunotherapies, highlighting the potential of pBAE polymers for advancements in this field. Graphical abstractKeywords
Funding Information
- Instituto de Salud Carlos III (AC22/00042)
- Fundación Científica Asociación Española Contra el Cáncer (TRNSC213882FORN)
- Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España (PID2021-125910OB-I00)
- Departament de Salut, Generalitat de Catalunya (TecnioSpring Industry)
- Fundación Ramón Areces (NanoLaf)
- Universitat Ramon Llull
This publication has 98 references indexed in Scilit:
- Poly (beta‐amino ester) as an in vivo nanocarrier for therapeutic nucleic acidsBiotechnology and Bioengineering, 2022
- Complex pBAE Nanoparticle Cell Trafficking: Tracking Both Position and Composition Using Super Resolution MicroscopyChemMedChem, 2022
- Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patientsCancer Immunology, Immunotherapy, 2020
- In Vivo Retargeting of Poly(beta aminoester) (OM‐PBAE) Nanoparticles is Influenced by Protein CoronaAdvanced Healthcare Materials, 2019
- Poly(β‐Amino Esters): Synthesis, Formulations, and Their Biomedical ApplicationsAdvanced Healthcare Materials, 2018
- mRNA Delivery System for Targeting Antigen‐Presenting Cells In VivoAdvanced Healthcare Materials, 2018
- Impact of molecular weight on the intrinsic immunogenic activity of poly(beta amino esters)Journal of Biomedical Materials Research Part A, 2017
- Hydrogel Doped with Nanoparticles for Local Sustained Release of siRNA in Breast CancerAdvanced Healthcare Materials, 2014
- Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer TherapeuticsCurrent Protocols in Pharmacology, 2013
- Subtle Changes to Polymer Structure and Degradation Mechanism Enable Highly Effective Nanoparticles for siRNA and DNA Delivery to Human Brain CancerAdvanced Healthcare Materials, 2012